» Articles » PMID: 32283831

Systems Biology Analysis of the Antagonizing Effects of HIV-1 Tat Expression in the Brain over Transcriptional Changes Caused by Methamphetamine Sensitization

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2020 Apr 15
PMID 32283831
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Methamphetamine (Meth) abuse is common among humans with immunodeficiency virus (HIV). The HIV-1 regulatory protein, trans-activator of transcription (Tat), has been described to induce changes in brain gene transcription that can result in impaired reward circuitry, as well as in inflammatory processes. In transgenic mice with doxycycline-induced Tat protein expression in the brain, i.e., a mouse model of neuroHIV, we tested global gene expression patterns induced by Meth sensitization. Meth-induced locomotor sensitization included repeated daily Meth or saline injections for seven days and Meth challenge after a seven-day abstinence period. Brain samples were collected 30 min after the Meth challenge. We investigated global gene expression changes in the caudate putamen, an area with relevance in behavior and HIV pathogenesis, and performed pathway and transcriptional factor usage predictions using systems biology strategies. We found that Tat expression alone had a very limited impact in gene transcription after the Meth challenge. In contrast, Meth-induced sensitization in the absence of Tat induced a global suppression of gene transcription. Interestingly, the interaction between Tat and Meth broadly prevented the Meth-induced global transcriptional suppression, by maintaining regulation pathways, and resulting in gene expression profiles that were more similar to the controls. Pathways associated with mitochondrial health, initiation of transcription and translation, as well as with epigenetic control, were heavily affected by Meth, and by its interaction with Tat in anti-directional ways. A series of systems strategies have predicted several components impacted by these interactions, including mitochondrial pathways, mTOR/RICTOR, AP-1 transcription factor, and eukaryotic initiation factors involved in transcription and translation. In spite of the antagonizing effects of Tat, a few genes identified in relevant gene networks remained downregulated, such as sirtuin 1, and the amyloid precursor protein (APP). In conclusion, Tat expression in the brain had a low acute transcriptional impact but strongly interacted with Meth sensitization, to modify effects in the global transcriptome.

Citing Articles

Identifying methamphetamine use predictors in HIV infection: Immune-dopaminergic signatures in peripheral leukocytes and the role of COMT genotype.

Basova L, Riley T, Franklin D, Delorme-Walker V, Lim W, Grant I Brain Behav Immun Health. 2024; 42:100873.

PMID: 39430881 PMC: 11490913. DOI: 10.1016/j.bbih.2024.100873.


MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology.

Basova L, Lindsey A, McGovern A, Rosander A, Delorme-Walker V, ElShamy W Viruses. 2023; 15(6).

PMID: 37376663 PMC: 10304659. DOI: 10.3390/v15061363.


HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.

Lopez Lloreda C, Chowdhury S, Ghura S, Alvarez-Periel E, Jordan-Sciutto K Cells. 2022; 11(19).

PMID: 36230925 PMC: 9564041. DOI: 10.3390/cells11192962.


Methamphetamine signals transcription of IL1β and TNFα in a reactive oxygen species-dependent manner and interacts with HIV-1 Tat to decrease antioxidant defense mechanisms.

Basova L, Vien W, Bortell N, Najera J, Marcondes M Front Cell Neurosci. 2022; 16:911060.

PMID: 36060276 PMC: 9434488. DOI: 10.3389/fncel.2022.911060.


Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.

Fattakhov N, Torices S, Stangis M, Park M, Toborek M Viruses. 2021; 13(9).

PMID: 34578464 PMC: 8473422. DOI: 10.3390/v13091883.


References
1.
Potash M, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J . A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A. 2005; 102(10):3760-5. PMC: 553332. DOI: 10.1073/pnas.0500649102. View

2.
Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield D . Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem. 2003; 278(15):13512-9. DOI: 10.1074/jbc.M209381200. View

3.
Thaney V, Sanchez A, Fields J, Minassian A, Young J, Maung R . Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol. 2017; 24(2):156-167. PMC: 5911244. DOI: 10.1007/s13365-017-0584-2. View

4.
Zhou B, Liu Y, Kim B, Xiao Y, He J . Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci. 2004; 27(3):296-305. DOI: 10.1016/j.mcn.2004.07.003. View

5.
Wang G, Pan Y, Seth P, Song R, Belcher L . Estimation of the Percentage of Newly Diagnosed HIV-Positive Persons Linked to HIV Medical Care in CDC-Funded HIV Testing Programs. Eval Health Prof. 2017; 41(4):474-492. PMC: 11290494. DOI: 10.1177/0163278717725372. View